Regeneron Says Large-Scale Human Genetics Starting to Generate New Drug Targets

Nov 16, 2017

|

Premium

NEW YORK (GenomeWeb) – Three years after Regeneron Pharmaceuticals began sequencing human exomes on a large scale and analyzing them along with electronic health records, the effort has started to bear fruit in the form of new drug targets and additional insights into existing ones.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Shaken Identity

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Free-Ish

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

This Week in PLOS

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

Isolation Worries

An opinion piece at Bloomberg discusses China's stance on genomic research.

Featured White Papers

DNA Quantification and Normalization with Promega QuantiFluor Dyes on the Fluent Laboratory Automation Solution

Nucleic Acid Quantification and Normalization by UV Measurement on the Fluent Laboratory Automation Solution

Maxwell HT Genomic DNA Extraction from Blood on the Fluent Automation Workstation

The Lifecycle of NGS Samples

Nov

29

Featured Webinar

Glass or Polymer? A Comparison for Use in In Vitro Diagnostic Biochips

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.

Dec

03

Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec

04

Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Dec

11

Featured Webinar

Assessing the Impact of Different Aneuploid Findings with Independent NGS Platforms

This webinar describes a study that used two independent next-generation sequencing (NGS) platforms to gain insight into the impact of different types of aneuploidies during preimplantation genetic testing.

Main menu